Guide Dose vs HIV PEP Pro

Guide Dose brings together clinical information, educational references, and clinical decision-support tools in a fast, clear, organized experience for iPhone and iPad. Developed by MedCalc LTDA, a Brazilian medical research and technology company, Guide Dose was created to support study, reference consultation, and the organization of clinical information. The app uses structured content, responsible language, and fluid navigation to help healthcare professionals and advanced students access medical information more clearly. Guide Dose does not replace clinical judgment, individualized prescribing, institutional protocols, official labeling, or government sources. Its purpose is to provide informational and educational support for review, consultation, and clinical workflow organization. FEATURES • Search by medication or indication. • Patient profile with age, weight, height, sex, and age range to contextualize readings and auxiliary tools. • Clinical references and official labeling organized in one environment. • Modules on physiology, medications, intubation pathways, and CPR support. • Clinical AI for informational support, with answers in an educational format. • Protocols and consultation flows for reviewing relevant topics. • Auxiliary tools grouped in a dedicated section, intended for reference use only. • Multilingual support for consultation in different languages. • Dark interface, readable typography, and fluid navigation within the Apple ecosystem. WHO IT IS FOR Physicians, nurses, pharmacists, and advanced students seeking a tool for study, reference consultation, and organization of clinical information. THE DIFFERENCE Guide Dose organizes clinical information, medical references, and support tools into a structured experience. The focus is clarity, review, medical education, and organization of health information. ABOUT MEDCALC LTDA MedCalc LTDA is a Brazilian company dedicated to research and innovation in medical technology. We develop digital tools that connect scientific evidence, medical education, and clinical information organization. CLINICAL CONTENT Guide Dose content is organized using medical literature, guidelines, official labeling, and recognized protocols. Critical information should always be confirmed with official sources, local guidelines, and institutional protocols. SUBSCRIPTIONS Guide Dose offers auto-renewable plans for full access: • Monthly Plan • Annual Plan Payment is charged to your Apple ID account at confirmation of purchase. The subscription renews automatically unless canceled at least 24 hours before the end of the current period. Manage or cancel in Settings > Apple ID > Subscriptions. PRIVACY Your data is treated seriously. Use fictitious data in demonstrations. In clinical settings, follow your institution’s protocols, applicable law, and best practices for data protection. Privacy Policy: https://guidedose.com.br/privacidade Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ UPDATES We continuously improve content, languages, performance, and stability. Download Guide Dose and get an organized tool for study, reference consultation, and clinical workflow support on iPhone and iPad. LEGAL NOTICE Guide Dose is a clinical support, study, and reference tool developed by MedCalc LTDA. It does not replace medical evaluation, prescribing, professional judgment, institutional protocols, official labeling, or official sources. Confirm doses, allergies, interactions, and clinical actions with your team, current guidelines, and primary sources. AI content is informational and educational and may contain inaccuracies. Use implies acceptance of the Terms of Use and Privacy Policy.

HIV PEP Pro is a clinical decision-support application designed to assist healthcare professionals in the assessment and management of HIV Post-Exposure Prophylaxis (PEP) based on Centers for Disease Control and Prevention (CDC) guidelines. The app follows a structured, step-by-step workflow aligned with current CDC recommendations for evaluating exposure risk, timing (72 hours), source HIV status, and patient-specific clinical factors. Key Features: • CDC guideline–based HIV PEP eligibility assessment • Time-dependent risk evaluation consistent with CDC exposure windows • Exposure-specific risk stratification following CDC definitions • Integrated CDC-aligned recommendations for: – HIV PEP – Sexually transmitted infection (STI) prophylaxis – Hepatitis B post-exposure management – Emergency contraception (when applicable) • Clear clinical summaries for point-of-care use • PDF export suitable for medical documentation • Designed for Emergency Medicine, Occupational Health, and Acute Care settings Intended Use: HIV PEP Pro is intended for use by licensed healthcare professionals only as a clinical decision-support tool based on CDC guidelines. It does not replace clinical judgment, institutional protocols, or specialist consultation. Disclaimer: This application provides guideline-based decision support and does not provide a medical diagnosis or treatment. Final clinical decisions must be made by the treating clinician in accordance with local policies and the latest CDC guidance.